Identifying Cancer Cachexia Using Clinical Reasoning AI – ASCO 2026

Press Release: Pangaea Expands its AI Platform to Support Decision-Making & Guideline-Concordance for MDT Tumor Boards Across Enterprise & Community Care

Microsoft & NVIDIA Documentary: Pangaea Data Closing Care Gaps

GO BACK

AI to Improve Outcomes: Finding Untreated & Under-treated At-Risk Patients

3:30 - 3:50PM CET, November 21st, Main Stage, Station F, Paris, France

Presentation

Session: AI to Improve Outcomes: Finding Untreated & Under-treated At-Risk Patients

Location: Main stage

Learn how a global pharmaceutical company applied Pangaea Data’s AI platform, PALLUX, to find more untreated and under-treated at-risk CKD and COPD patients with ~90% accuracy. This work is now being scaled across healthcare providers globally.

Demo Station

Location: Microsoft Booth (Booth 7)

Learn about Pangaea’s AI platform, PALLUX, is configured on clinical guidelines to find more untreated (undiagnosed, misdiagnosed, miscoded, at-risk, uncontrolled) and under-treated patients for hard-to-diagnose conditions for screening and treatment at the point of care. This helps to find more suitable patients who would otherwise be missed despite the information available in their records, due to treatment for other conditions or administrative reasons.

Register to meet us through the form below or email us at info@pangaeadata.ai

Register to Meet Us

Presenters & Attendees

Ms. Karine Reynaud
Healthcare & Life Science Director,
Microsoft
Dr. Jingqing Zhang
Head of AI,
Pangaea Data
Dr. Meredith Giblin
Biomedical Scientist,
Pangaea Data